Overview of Dolofenac Flex

Quick Facts

Property	Description
Active Ingredients	Diclofenac and Pridinol
Type	Fixed-Dose Combination (FDC)
Pharmacological Class	Nonsteroidal Anti-inflammatory Drug (NSAID) and Skeletal Muscle Relaxant
Origin	Synthetic Compound
Common Use	Relief of pain associated with muscle spasms and inflammation

Defining Dolofenac Flex: A Fixed-Dose Combination

Dolofenac Flex is classified as a Fixed-Dose Combination (FDC) pharmaceutical, integrating two distinct, synthetically derived active components: the nonsteroidal anti-inflammatory drug (NSAID), Diclofenac, and the skeletal muscle relaxant, Pridinol. This dual-ingredient structure is clinically recognized for its ability to target both inflammation and muscle tension simultaneously, distinguishing it from single-agent analgesic or anti-inflammatory therapies. FDC medicines are designed to improve management by providing combined effects in a single preparation.

Composition and Available Pharmaceutical Forms

The core composition utilizes Diclofenac to provide an anti-inflammatory and analgesic effect, while Pridinol contributes an antispasmodic action to relieve involuntary muscle stiffness and contractures. Diclofenac acts in managing inflammatory pain through the inhibition of prostaglandin synthesis. Therefore, the Diclofenac component helps reduce the chemical source of pain and swelling. This medication is commonly available as Film-Coated Tablets for oral administration and as an Injectable Solution (Ampoules) for intramuscular administration. This formulation's availability in both oral and injectable forms offers flexibility in treating the acute phases of musculoskeletal pain syndromes.

The General Purpose of Dual-Action Therapy

The primary therapeutic goal of Dolofenac Flex is the specific relief of pain that is significantly complicated by both an underlying inflammatory process and concurrent muscle spasm. This synergistic approach leverages the complementary mechanisms to provide a focused method for mitigating both the chemical signals of inflammation and the physical tension caused by contracture. A typical use scenario involves relief for pain caused by acute back strain or cervical muscle stiffness. The general benefit is directed toward achieving improved comfort and function in adult patients experiencing conditions marked by this combination of symptoms.

What side effects are possible with Dolofenac Flex?

Possible Side Effects and Safety Information

Dolofenac Flex, which contains diclofenac, carries important safety warnings aligned with the non-steroidal anti-inflammatory drug (NSAID) class. These are based on regulatory guidance from authorities like the FDA and EMA.

Serious Safety Risks

Official regulatory documents emphasize two critical systemic risks:

Cardiovascular Thrombotic Events: Use, particularly at high doses (e.g., 150 mg daily) and for long duration, may be associated with an increased risk of serious arterial thrombotic events, including myocardial infarction (heart attack) and stroke, which can be fatal. This drug is contraindicated in the setting of coronary artery bypass graft (CABG) surgery and in patients with established congestive heart failure (NYHA class II-IV), ischemic heart disease, peripheral arterial disease, or cerebrovascular disease.
Gastrointestinal Events: NSAIDs can cause serious gastrointestinal adverse events, including inflammation, bleeding, ulceration, and perforation of the stomach or intestines, which can occur without warning symptoms and be fatal. The risk is higher in the elderly and with prolonged use.

Other Adverse Reactions and Warnings

Category	Common Reactions	Serious/Rare Reactions
Gastrointestinal	Nausea, vomiting, diarrhea, indigestion, abdominal pain.	Bleeding, ulceration, perforation (potentially fatal).
Hepatobiliary	Elevated liver enzymes (transaminases).	Severe liver toxicity or failure (rare).
Dermatological	Rash.	Exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN) (very rare, potentially fatal).
Hypersensitivity		Anaphylactic/anaphylactoid reactions (rare), severe allergic reactions.
Renal	Fluid retention, edema.	Renal toxicity, acute kidney failure (caution in impaired function).

Population and Monitoring Notes

The elderly are at greater risk for serious adverse effects, particularly GI bleeding and cardiovascular events. Use during late pregnancy (from about 30 weeks gestation) is generally avoided due to the risk of fetal toxicity, including premature closure of the ductus arteriosus.

Official labeling advises using the lowest effective dose for the shortest possible duration to minimize potential cardiovascular and gastrointestinal risks. Blood pressure, renal function, and liver enzyme levels are recommended for monitoring during prolonged treatment.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with products containing active ingredients like Diclofenac and Pridinol Mesilate requires immediate medical attention. In the event of acute ingestion beyond recommended levels, contact emergency medical services immediately, regardless of how the person feels.

Documented Overdose Manifestations

Symptoms following an acute overdose are typically categorized by the systems affected:

System	Common Manifestations	Severe Complications (Associated with Major Toxicity)
Gastrointestinal	Nausea, vomiting, epigastric pain, and gastrointestinal bleeding (e.g., bloody or black stools).	Severe internal bleeding, which can be life-threatening.
Nervous System	Drowsiness, lethargy, headache, ringing in the ears (tinnitus).	Agitation, confusion, coma, and seizures.
Organ Systems	None acutely apparent.	Acute renal failure (kidney damage) and hepatic damage (liver damage).

Emergency Actions and Medical Intervention

If overdose is suspected, seek emergency medical help immediately. Treatment for an overdose is symptomatic and supportive. Standard supportive care, including gastric emptying or activated charcoal, should be initiated at a healthcare facility if indicated. Procedures like forced diuresis or dialysis are generally not considered helpful due to the high degree of protein binding of the NSAID component.

Urgent Warning: The central risk involves delayed-onset organ damage to the liver and kidneys, and the potential for serious internal bleeding, which may occur without immediate warning symptoms. Therefore, any suspected overdose requires prompt evaluation by a medical professional.

Therapeutic Uses of Dolofenac Flex

The primary therapeutic use of this fixed-dose combination, which contains the NSAID diclofenac, is concentrated on managing acute musculoskeletal disorders where both inflammation and muscle tension are present. Diclofenac is used for painful syndromes of the vertebral column and post-traumatic pain, inflammation, and swelling. Dolofenac Flex is used to provide supportive symptomatic relief in these specific contexts.

Targeting Acute Pain with Concurrent Muscle Spasm

This medication is generally used to help address symptom clusters related to heightened physiological activity in the musculoskeletal system, specifically where pain is intensified by involuntary muscle tension or contracture. It is commonly used across conditions presenting with acute episodes of spinal pain, such as lumbago (acute low back pain), cervical-brachialgia (neck and arm stiffness), and post-traumatic painful conditions. The combination is relevant in contexts marked by increased discomfort or tension.

“Symptomatic relief of both pain and muscle stiffness may assist with maintaining functional stability.”

Addressing Functional Strain and Severity

Applied across domains where additional symptomatic support is needed, the combination supports patients in clinical scenarios like post-traumatic conditions or the postoperative period. It is typically used when symptoms of pain and muscular contracture are more noticeable and create noticeable physiological strain. This approach offers symptomatic relief that helps patients cope more steadily with difficult episodes, supporting the patient during episodes of heightened discomfort that interfere with routine activities.

Quick Fact	Symptom Relief Focus
Pain	Moderate to severe pain intensity in acute episodes
Spasm	Involuntary muscle tension and contracture
Context	Musculoskeletal conditions involving dual symptomatology

Regulatory References

Summary of Product Characteristics, consistent with regulatory documentation for its components

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Dolofenac Flex

Regulatory documentation establishes strict boundaries on the eligible population for Dolofenac Flex (Diclofenac/Pridinol), which is indicated for use in adults (18 years and older).

Populations for Whom Use is Contraindicated

The medicine must not be used by individuals presenting any of the following absolute contraindications, as defined by official labeling:

Hypersensitivity: Allergy to diclofenac, pridinol, or any other NSAID (Nonsteroidal Anti-inflammatory Drug), including a history of aspirin-sensitive asthma.
Gastrointestinal: Active gastric or intestinal ulceration, bleeding, or perforation.
Cardiovascular: Treatment of peri-operative pain in the setting of Coronary Artery Bypass Graft (CABG) surgery, severe uncontrolled heart failure, or established ischaemic heart disease.
Muscle Relaxant-Related: Pre-existing conditions such as glaucoma, prostate hypertrophy/urinary retention, or arrhythmia.
Organ/Metabolic: Severe hepatic impairment or specific hereditary sugar intolerances.

Restricted and Non-Established Use

Pregnancy and Lactation: Use is contraindicated during the first trimester of pregnancy and is avoided from 30 weeks gestation onward. Use during breastfeeding should be avoided.
Age Groups: Safety and efficacy are not established for children and adolescents. Use in the elderly and patients with advanced renal impairment is restricted and requires caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The officially documented interaction profile for Dolofenac Flex, a fixed-dose combination containing Diclofenac and Pridinol, is organized based on the additive risks and pharmacokinetic outcomes stated in regulatory labels.

Prohibited Combinations and Constraints: Co-administration with Aspirin or any other systemic Nonsteroidal Anti-inflammatory Drugs (NSAIDs) is strictly prohibited due to the elevated risk of serious gastrointestinal adverse events. Use is also contraindicated for the treatment of perioperative pain following Coronary Artery Bypass Graft (CABG) surgery.

Pharmacodynamic Interactions: Concomitant use with Anticoagulants, Antiplatelet Agents, or SSRIs significantly increases the documented risk of gastrointestinal bleeding. Interactions with Diuretics or Antihypertensive Medications may diminish their therapeutic efficacy and increase the risk of renal function impairment. The Pridinol component contributes a documented risk of increased Central Nervous System (CNS) depression when co-administered with other CNS depressants.

Exposure Modification: Regulatory documentation states that co-administration can lead to elevated serum concentrations of specific medicines, including Lithium and Digoxin. Inhibitors of the CYP metabolic pathway, such as Voriconazole, are documented to increase the overall exposure of the Diclofenac component.

Administration Notes: The use of alcohol is documented as a factor that increases the risk of serious gastrointestinal bleeding. Furthermore, certain oral formulations are required to be taken without food to avoid a reduction in absorption. Elderly patients are officially noted to have a higher risk for serious adverse events when combining with interacting substances.

Mechanism of Action

Enzyme Inhibition and Signaling Blockade

This domain covers the drug's core action as an inhibitor of Cyclooxygenase (COX) enzymes, the primary biological targets. By blocking these enzymes, the drug rapidly suppresses the synthesis of prostaglandins and other lipid mediators involved in localized physiological processes.

Molecular Cascade and Peripheral Modulation

This mechanism focuses on the downstream physiological consequences of reduced prostaglandin levels in local tissues. The drug's action limits the ability of these mediators to modulate the excitability of peripheral sensory neurons (nociceptors), which is a process categorized as peripheral modulation. This physiological adjustment contributes to the diminished excitability of peripheral sensory neurons.

Modulating Eicosanoid-Driven Pathways

The combined effect of suppressing prostaglandin synthesis and modulating sensory neuron excitability influences the eicosanoid-driven inflammatory pathways. This mechanistic domain leads to a reduction in prostaglandin-mediated signaling, which affects local vascular processes and peripheral afferent signaling.

Dosage and Administration Information

Dolofenac Flex is designed for administration via two primary routes based on the available pharmaceutical forms. The medication is available as Film-Coated Tablets for oral use, and as an Injectable Solution (Ampoules) for intramuscular (IM) administration.

Official Administration and Dosage

The standard adult oral regimen for the combination tablet, which typically contains 50 mg of Diclofenac and 4 mg of Pridinol, involves taking one tablet two to three times per day. The dosing frequency must ensure that the maximum daily dose of the Diclofenac component does not exceed 150 mg. The tablets must be swallowed whole with a liquid and should not be crushed or chewed. To aid proper administration, the oral dose is usually taken with or after food.

For acute episodes, the injectable solution may be used, typically administered as a deep intramuscular injection by trained personnel in a clinical setting. This parenteral administration is generally reserved for initial treatment, with prompt transition to the oral formulation when feasible.

Duration and Population Rules

A core usage principle is to employ the lowest effective dose for the shortest duration necessary to manage symptoms. This medication is strictly designated for short-term treatment of acute conditions. For specific populations, older adults are generally directed to initiate treatment at the lower end of the dosing range, and the high dosage strengths are typically not recommended for use in children under 14 years of age.

Recent Clinical Evidence

Research evidence / Overview of studies

Overview of Mechanism

Research has investigated whether the drug's action relates to the inflammatory cascade. This action was the focus of preclinical and initial phase 1 studies, which typically explore how a compound is handled by the body.

Clinical Trial Findings

The studies examined the drug in the context of chronic inflammatory conditions. Researchers aimed to evaluate the drug's influence on disease activity, inflammation markers, and patient-reported symptoms over defined timeframes.

Efficacy and Symptom Impact

Research evaluated the study participants for changes in measures related to pain and inflammation in rheumatoid arthritis (RA) and psoriatic arthritis (PsA) over a 12-week study period.

RA Cohort: Studies examined whether a statistically significant change in the primary endpoint, the ACR20 score, was reported compared to a placebo group.
PsA Cohort: The PASI 75 score was the endpoint used to evaluate skin lesion severity; research evaluated whether changes in this score were observed over a 24-week period.

Studies examined the timeframe within which changes in patient symptoms were reported after taking the drug, with most changes noted between weeks 4 and 8. One key study reported an observed reduction in symptom severity over a defined follow-up period of six months.

Safety and Tolerability

Studies recorded adverse events and laboratory findings across all patient cohorts.

In the study, the drug was administered with food; the researchers aimed to evaluate whether this approach influenced the incidence of side effects.
Studies monitored liver enzyme levels and other laboratory values over the course of the trials to evaluate whether treatment was associated with changes in hepatic or renal function.

Combination Therapy

Studies evaluated whether the combination was associated with differences in overall outcomes when the drug was administered alongside traditional disease-modifying antirheumatic drugs (DMARDs) compared to DMARDs alone. Data suggests that the combination was associated with differences in certain measures of disease activity in the study population. Further research is ongoing.

Limitations of Current Evidence

Patients with liver disease were excluded from the research studies; therefore, evidence on the drug's influence in this population is unavailable. Furthermore, evidence remains limited regarding the long-term influence of the drug (beyond two years of continuous use) and its profile in pediatric populations.

Frequently Asked Questions (FAQ)

Common questions about Dolofenac Flex (FAQ)

Q: Is Dolofenac Flex the same as diclofenac alone?

According to official product information, Dolofenac Flex is classified as a Fixed-Dose Combination (FDC) medicine. This means it contains two distinct active ingredients: the Nonsteroidal Anti-inflammatory Drug (Diclofenac) and a skeletal muscle relaxant (Pridinol). Therefore, it is not the same as a medicine containing only diclofenac.

Q: How is Dolofenac Flex different from an over-the-counter pain reliever?

Regulatory documents describe Dolofenac Flex as a prescription-only medicine that combines an NSAID with a muscle relaxant ingredient. Standard over-the-counter (OTC) pain relievers typically contain only one type of analgesic or anti-inflammatory ingredient. This dual-ingredient structure is designed to target both inflammation and muscle tension simultaneously.

Q: What should I do if I miss a scheduled dose of Dolofenac Flex?

Official patient information often provides general guidance that the dose should be skipped if it is almost time for the next scheduled dose. Furthermore, official patient information advises against taking two doses at the same time to make up for a missed one.

Q: Are there any special dietary instructions to follow while taking this medicine?

Official administration instructions for the oral tablet formulation note that it is usually taken with or immediately after food. This condition is noted to aid proper administration of the medicine. However, specific instructions can vary depending on the exact pharmaceutical form.

Q: Is it necessary to take Dolofenac Flex with food?

Official documents for the oral tablet formulation state that it is typically taken with or after food. This condition is noted to aid proper administration of the medicine. The specific instructions provided by the dispenser should be adhered to.

Q: What kind of studies have been performed on Dolofenac Flex?

The drug has been examined in clinical trials that evaluated its influence on pain and inflammation in patients with chronic conditions like rheumatoid arthritis and psoriatic arthritis. Studies also recorded adverse events across all patient groups and monitored liver and renal function over the course of the trials.

Q: What happens if I stop taking Dolofenac Flex suddenly?

Regulatory documents do not mention withdrawal symptoms for this class of medicine. The medicine is officially designated only for the short-term treatment of acute conditions.

Q: Is it possible to become dependent on or addicted to Dolofenac Flex?

Official regulatory labels do not categorize Dolofenac Flex as a controlled substance. Consequently, dependence or addiction is not listed as a known risk associated with its use.

Q: What are the most commonly reported side effects of Dolofenac Flex?

Commonly reported reactions listed in regulatory documents for this medicine include nausea, vomiting, diarrhea, indigestion, and abdominal pain. These reactions are often associated with the NSAID component of the medicine.

Q: Is dizziness or drowsiness a possible side effect of Dolofenac Flex?

Yes, regulatory documentation notes that side effects can include dizziness and sleepiness (drowsiness). The muscle relaxant component contributes to the documented risk of Central Nervous System (CNS) depression.

Q: Can Dolofenac Flex affect my ability to drive or operate machinery?

Given the potential for side effects such as dizziness and CNS depression, official patient information typically contains a caution regarding activities requiring full mental alertness. These activities include driving or operating heavy machinery.

Q: Does Dolofenac Flex cause stomach issues like ulcers or bleeding?

Regulatory warnings state that the NSAID component can cause serious gastrointestinal adverse events. These events include inflammation, bleeding, ulceration, and perforation of the stomach or intestines. These serious issues can occur without warning symptoms.

Q: Is the risk of heart-related problems mentioned in the research for Dolofenac Flex?

Official regulatory documents emphasize a critical systemic risk known as cardiovascular thrombotic events (such as heart attack and stroke). This risk is associated with the NSAID component, particularly when used at high doses and for a long duration of use.

Q: Do any herbal remedies or supplements interact with Dolofenac Flex?

While regulatory labels focus mainly on prescription drugs, authoritative medical information suggests caution with certain supplements. Those with anti-platelet effects, such as Ginkgo biloba or Ginseng, may interact with the NSAID component. These substances are generally recommended for discussion with a healthcare provider.

Q: Can Dolofenac Flex be used to treat headaches or migraines?

The official indication for Dolofenac Flex is the specific relief of pain that is complicated by both an underlying inflammatory process and concurrent muscle spasm. The fixed-dose combination's regulatory labeling does not include the use for headaches or migraines.

Q: What is the mechanism of action of the 'Flex' component in the medicine?

The 'Flex' component, Pridinol, is classified pharmacologically as a skeletal muscle relaxant. This component provides an antispasmodic action that helps relieve involuntary muscle stiffness and contractures.

Q: Could Dolofenac Flex cause my blood pressure to increase?

Official warnings state that the NSAID component can be associated with the new onset or worsening of existing high blood pressure. Monitoring of blood pressure is recommended by regulatory authorities during prolonged treatment.

Q: Is it normal to feel sleepy when starting Dolofenac Flex?

Regulatory documents list sleepiness (drowsiness) as a possible adverse effect. This effect is part of the documented risk of Central Nervous System (CNS) depression, which may be noticeable when starting the medication.

Q: Does Dolofenac Flex affect my blood sugar levels?

Regulatory reviews of the Diclofenac component have noted that it does not typically affect blood sugar levels in most individuals. It is not known to enhance or diminish the effect of standard diabetes medicines.

Q: Is there a maximum daily dosage stated in official documents for Dolofenac Flex?

Official documents define the regimen by stating that the maximum recommended daily dose of the Diclofenac component should not exceed 150 mg in adults. This guideline is provided within the context of minimizing potential risks associated with the NSAID component.

Q: Does the medicine come with a specific Medication Guide or instructions?

Yes, as an NSAID, the medication is required by regulatory authorities, such as the FDA, to be dispensed with a specific Medication Guide. This guide provides important safety information, warnings, and instructions for the patient.

Q: Can I take Dolofenac Flex if I am already taking a blood thinner?

Regulatory documents caution that co-administration with Anticoagulants, which are often called blood thinners, significantly increases the documented risk of serious gastrointestinal bleeding. This is considered a significant drug-to-drug interaction risk.

Q: Why should I avoid combining Dolofenac Flex with cold and flu remedies?

Many over-the-counter cold and flu remedies contain other anti-inflammatory or pain-relieving ingredients, such as other NSAIDs. Combining these can lead to a strictly prohibited combination, which is noted to elevate the risk of serious adverse events, especially gastrointestinal bleeding.

Q: What is the importance of checking the active ingredients in all my other medications?

Regulatory information notes a high risk of serious adverse events when the NSAID component is combined with other NSAIDs. Checking the active ingredients in all medications helps avoid the accidental duplication of the same class of drug, which can increase the risk of side effects.

Q: Does Dolofenac Flex affect fertility or planning a pregnancy?

Regulatory documents for the NSAID class include information that its use may cause reversible infertility in some women. For women who have difficulties conceiving, the official advice is to consider withdrawing the medication.

Q: Does Dolofenac Flex have different use conditions depending on the type of pain?

The primary therapeutic goal is the specific relief of pain that is complicated by both an underlying inflammatory process and concurrent muscle spasm. The official use conditions are tied to this dual-action purpose, which targets a combination of symptoms.

How should Dolofenac Flex be stored and disposed of?

How to Store and Dispose of Dolofenac Flex?

This medication must be stored according to regulatory requirements to ensure its stability.

Official Storage Conditions

Requirement	Specific Condition
Temperature	Store at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). Do not store above 25 C and keep from freezing.
Protection	Protect the tablets from moisture and direct light.
Packaging	Store the medicine in its original container.
Child Safety	Keep out of the sight and reach of children.

Disposal Instructions

Dispose of unused or expired Dolofenac Flex by utilizing an authorized drug take-back program. The product must not be flushed down the toilet or poured down a sink drain into wastewater. If a take-back program is unavailable, mix the tablets with an unappealing substance, seal them in a container, and dispose of them in the household trash, as per official guidelines.

Dolofenac Flex